Normal Physiology: Clinical Trials

5 trials for Normal Physiology, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 recruiting. 5 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 15Completed 3, Not yet recruiting 1, Recruiting 1

Follow Normal Physiology: new trials by email Literature Review of Normal Physiology trials Research Report on Normal Physiology

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making
continuous Theta Burst Stimulation (cTBS), intermittent Theta Burst Stimulation (iTBS), sham Theta Burst Stimulation (sham TBS) - Normal Physiology
Early Phase 1RecruitingNational Institute on Drug Abuse (NIDA)6002026-11-122026-11-09
Causal Mechanisms of Odor-Guided Behavior in Humans
TUS PirC, TUS Amy, TUS Sham - Normal Physiology
Early Phase 1Not yet recruitingNational Institute on Drug Abuse (NIDA)802026-11-122026-11-09
Brain Dopaminergic Signaling in Opioid Use Disorders
[11C]raclopride plus placebo, [11C]raclopride plus drug, [11C]NNC-112 - Normal Physiology, Opioid Use Disorders
Early Phase 1CompletedNational Institute on Alcohol Abuse and Alcoholism (NIAAA)1532017-08-172026-09-08
Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People
[18F]florbetaben - Normal Physiology
Early Phase 1CompletedNational Institute on Alcohol Abuse and Alcoholism (NIAAA)222016-05-022026-09-14
Reliability of the Human Brain Connectome
F-18FDG, MRI - Normal Physiology
Early Phase 1CompletedNational Institute on Alcohol Abuse and Alcoholism (NIAAA)1122015-06-082026-10-08

Narrower conditions

Opioid-Related Disorders (1)  ·  Sleep Deprivation (1)

Broader conditions

Mental Disorders (2)  ·  Chemically-Induced Disorders (1)  ·  Dyssomnias (1)  ·  Narcotic-Related Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Sleep Wake Disorders (1)  ·  Substance-Related Disorders (1)

Interventions

4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene (1)  ·  Pharmaceutical Preparations (1)

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA) (3)  ·  National Institute on Drug Abuse (NIDA) (2)

Countries

United States (5)

Top investigators

Dardo G Tomasi, Ph.D. (2)  ·  Thorsten Kahnt, Ph.D. (2)  ·  Nora D Volkow Adler, M.D. (1)

Results publications

PMID 34264865, PMID 40101961